Actualités des associations de patients – JAMRF25

Actualités des associations de patients – JAMRF25

🎙 Laure Dorey 👥 2K 📅 February 18, 2026 ⏱ 13 min 👁 32 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

patient associationsrare liver diseasescholestasispatient supporthealthcare collaboration

Summary

In this presentation from the Annual Rare Liver Diseases Days (JAMRF25), Laure Dorey, representing the patient association AMFE, provides updates on various initiatives and projects. She announces the evolution of the Peach application, which will be renamed and expanded to include adult patients with cholestatic liver diseases, with support from pharmaceutical companies. She introduces ELDA (European Liver Disease Advocates Alliance), a collaboration of six associations across five countries, and mentions the upcoming Livgo website for traveling patients. The presentation covers the ‘alerte jaune’ campaign, which provides educational kits to healthcare professionals to improve early diagnosis of biliary atresia and neonatal cholestasis. She discusses the development of patient information videos, which will be translated into English and adapted for adults. Updates on vaccination information on the AMFE website and plans for a dedicated healthcare professional space are also mentioned. Additionally, she highlights the social fund for patients in need, and provides information about the Lemoine law regarding bank loans for patients, emphasizing the importance of informing patients about their rights. The talk concludes with an invitation for further questions.

178 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation offers valuable, practical information for healthcare professionals and patients, detailing concrete resources and initiatives. The argumentation is based on the speaker’s direct involvement and collaboration with medical experts, lending credibility. However, the talk is largely descriptive and lacks critical analysis or evidence-based justification for the approaches described.

Scientific Rigor, Source Quality, Title Accuracy

The speaker does not cite formal scientific sources, but references collaborations with medical professionals and institutions. The title accurately reflects the content, which is a news update from patient associations. The information is presented as expert opinion based on experience, but without formal citations, the scientific rigor is moderate.

113 words

Title / Content Match

The title accurately reflects the content, which is a presentation of patient association news and updates.

Quality & Reliability

7/10

The speaker is a patient association representative, not a medical researcher, but the content is based on direct experience and collaboration with healthcare professionals. The information is practical and up-to-date, but lacks formal citations and peer review.

Key Moments

Cited Sources

  • FILFOIE website — Mentioned as the organization's website for further information.
  • AMFE website — Referenced as the association's site with updated vaccination information.

Concurring Sources

  • FILFOIE website — Official site of the rare liver disease network, consistent with the presentation's context.

Contribution & Novelties

This presentation provides an update on patient association initiatives, including the evolution of digital tools like the Peach app and the creation of European collaborations. It highlights practical resources for healthcare professionals and patients, such as the ‘alerte jaune’ kits and the upcoming Livgo website. The talk also informs about legal rights for patients regarding bank loans, which is a less commonly discussed topic.

Pour aller plus loin :

108 words

Radar Profile

The radar profile shows moderate scores across all dimensions, with a slightly higher score in information quantity and quality, reflecting the practical and up-to-date nature of the content. The lower technical level indicates that the presentation is accessible to a broad audience.

Reliability 7/10